Outcome in moderate haemophilia

Blood Transfusion

Volumn 12, Issue SUPPL.1, 2014, Pages

  Den Uijl, Ingrid ^a,b   Biesma, Douwe ^b   Grobbee, Diederick ^b   Fischer, Kathelijn ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

HJHS; Joint bleed; Moderate haemophilia; Physical activity

Indexed keywords

ADULT; AGE OF ONSET; FACTOR IX; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HEMORRHAGE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; MOTOR ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893936577     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0091-12     Document Type: Review

References (16)

1. Report on the Global Survey 2008. World federation of Haemophilia. Available at: www1.wfh.org/publications/files/ pdf-1429.pdf. Accessed on: 27/01/2011.
2. Ahlberg A. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965; Suppl. 77: 3-132.
3. Plug I, van der Bom JG, Peters M, et al. Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood 2004; 104: 3494-500.
4. den Uijl IEM, Fischer K, van der Bom JG, et al. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia. Haemophilia 2009; 15: 83-90.
5. Lindvall K, Colstrup L, Wollter IM, et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia. Haemophilia 2006; 12: 47-51.
6. Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia 2006; 12: 518-25.
7. VanderZee KI, Sanderman R, Heyink JW, de Haes H. Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status. Int J Behav Med 1996; 3: 104-22.
8. Stolk EA, Busschbach JJ. Validity and feasibility of the use of condition-specific outcome measures in economic evaluation. Qual Life Res 2003; 12: 363-71.
9. van Genderen FR, Westers P, Heijnen L, et al. Measuring patients' perceptions on their functional abilities: validation of the Haemophilia Activities List. Haemophilia 2006; 12: 36-46.
10. Over J. Methodology of the one-stage assay of factor VIII (VIII:C). Scand J Haematol Suppl 1984; 41: 13-24.
11. Koch B, Luban NL, Galioto FM, et al. Changes in coagulation parameters with exercise in patients with classic hemophilia. Am J Hematol 1984; 16: 227-33.
12. Preston FE, Kitchen S, Jennings I, et al. SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria? J Thromb Haemost 2004; 2: 271-4.
13. Lowe GD, Ludlam CA. Less severe bleeding in hemophilia B than in hemophilia A. J. Thromb Haemost 2008; 6: 1982-3.
14. Fischer K, van der Bom JG, Mauser-Bunschoten EP, et al. Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia. Thromb Haemost 2000; 84: 977-80.
15. Fischer K, van der Bom JG, Mauser-Bunschoten EP, et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002; 99: 2337-41.
16. Astermark J, Petrini P, Tengborn L, et al. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol 1999; 105: 1109-13.